Concepedia

Edgar T. Overton

ET

Statistics

Publications

140

Citations

10K

H-Index

53

Active since

2005

Affiliations

University of Alabama at Birmingham(Current)

Washington University in St. Louis

Harvard University

Cancer Research And Biostatistics

Duke University

Edgar T. Overton is an author at University of Alabama at Birmingham specializing in antiretroviral therapy, medicine, and hiv epidemiology.

ORCID

Publications per year

2005–2024

140

Publications

140

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement et al. · New England Journal of Medicine · 2021 · 853 citations · Full text

, , +16

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

Katharine J. Bar, Michael C. Sneller, Linda J Harrison et al. · New England Journal of Medicine · 2016 · 475 citations · Full text

, , +13

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Chloe Orkin, Keikawus Arastéh, Miguel Górgolas Hernández-Mora et al. · New England Journal of Medicine · 2020 · 464 citations · Full text

, , +14

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Steven Grinspoon, Kathleen V. Fitch, Markella V. Zanni et al. · New England Journal of Medicine · 2023 · 455 citations · Full text

, , +10

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

David Wyles, Peter Ruane, Mark Sulkowski et al. · New England Journal of Medicine · 2015 · 422 citations · Full text

, , +17

1–5 of 140